Quantcast
Last updated on April 23, 2014 at 1:22 EDT

Latest Exenatide Stories

2013-10-06 23:02:25

The Drug Risk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com Dallas, TX (PRWEB) October 06, 2013 The diabetes drug resource center at DrugRisk.com is announcing updated information for patients taking the medication Byetta. After lawsuits alleging the drug caused cancer were consolidated to a special court*, that court has now scheduled an initial hearing for later this month. DrugRisk...

2013-10-05 23:03:56

DrugRisk is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com New York, NY (PRWEB) October 05, 2013 The diabetes drug resource center at DrugRisk.com is alerting patients taking the medications Januvia or Janumet of new information on the site. Updated records from a special federal multidistrict litigation court show the number of lawsuits alleging the drugs caused pancreatic cancer has grown*. The...

2013-10-03 12:26:25

Increases patent portfolio to 11 issued and 24 pending JERUSALEM, October 3, 2013 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has received two additional patent approvals for its platform Protein Oral Delivery (POD(TM)) technology in Japan and Canada. Both granted patents are titled "Methods and Compositions for Oral Administrations of Proteins." About POD(TM)...

2013-09-30 23:22:37

The Firm is currently investigating Byetta lawsuits on behalf of patients who may have developed pancreatic cancer due to the use of the Type 2 diabetes drug. New York, NY (PRWEB) September 30, 2013 Dozens of Byetta lawsuit (http://www.byettalawsuit2013.com/) claims filed on behalf of plaintiffs who allegedly developed pancreatic cancer due to their use of the Type 2 diabetes drug have begun to move forward in a multidistrict litigation recently established in U.S. District Court,...

2013-09-28 23:03:38

http://www.DrugNews.net is the web’s premier source for prescription device warnings, research, side effects and legal news. Visit the DrugNews Center today. Los Angeles, CA (PRWEB) September 28, 2013 The diabetes drug safety center at DrugNews.net is advising patients taking the medications Januvia or Janumet of new information on the site. The latest court records show the number of lawsuits alleging the drugs caused cancer have risen*. DrugNews provides those patients taking popular...

2013-09-27 23:25:39

The Drug Risk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com Los Angeles, CA (PRWEB) September 27, 2013 The diabetes drug resource center at DrugRisk.com is announcing updated information for patients taking the medication Byetta. After lawsuits alleging the drug caused cancer were consolidated to a special court, the latest court records show cases are growing*. DrugRisk is a free...

2013-09-26 08:27:14

Improvements in several indicators of diabetes management, including perceptions about hyperglycaemia and weight, observed for investigational GLP-1 receptor agonist BARCELONA, Spain, Sept. 26, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive patient-reported health outcomes from a Phase III clinical trial of dulaglutide, an investigational, long-acting glucagon-like peptide 1 (GLP-1) receptor agonist being studied as a once-weekly treatment for type 2 diabetes....

2013-09-25 08:29:39

JERUSALEM, September 25, 2013 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has been invited to participate in an exclusive Israeli Biotech Corporate Day, hosted by Barclays [http://group.barclays.com/home ] on September 30, 2013 in Zurich, Switzerland. The event is designed to connect prominent Israeli biotech companies with Barclays' investors for future potential...

2013-09-24 23:00:31

DrugRisk is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com New York, NY (PRWEB) September 24, 2013 The diabetes drug safety center at DrugRisk.com is announcing new information on the site for patients taking the medications Januvia or Janumet. A federal multidistrict litigation court recently created to handle lawsuits alleging the drugs caused pancreatic cancer has issued the latest update on case...

2013-09-23 23:34:29

http://www.DrugNews.net is the web’s premier source for prescription drug warnings, research, side effects and legal news. Visit the DrugNews Center today. New York, NY (PRWEB) September 23, 2013 The diabetes drug resource center at DrugNews.net is announcing updated information for patients taking the medication Byetta. A federal multidistrict litigation court recently created to handle lawsuits alleging the drug caused pancreatic cancer has issued the latest update on case numbers*....


Latest Exenatide Reference Libraries

36_67c6fec75293d7e1e91a0c52aa692cf7
2005-06-22 14:17:05

The Gila monster (Heloderma suspectum) is one of the two known species of venomous lizards. This lizard lives in the deserts of the southwestern USA and northwestern Mexico. It is a heavy, slow moving lizard and can measure up to 2 feet (60 cm) in length. Its skin has the appearance of beads in the colors black, pink, orange, and yellow, laid down in intricate patterns across the animal's body. Unlike a snake, the Gila monster envenomates its victim through grooves in the teeth of its...

More Articles (1 articles) »